Switch to:
More From Other Websites
Teva, Allergan win U.S. antitrust approval for generics deal Jul 27 2016
Teva, Allergan win U.S. antitrust approval for generics deal Jul 27 2016
Teva expect to close $40.5B Allergan generic deal next week Jul 27 2016
Teva expect to close $40.5B Allergan generic deal next week Jul 27 2016
[$$] Teva, Allergan Get FTC Approval for Generics Purchase Jul 27 2016
FTC approves Teva's $40.5B deal for Allergan's generics business Jul 27 2016
ALLERGAN PLC Files SEC form 8-K, Other Events Jul 27 2016
Teva purchase of Allergan generics business approved with conditions Jul 27 2016
Third Point's 1st-half returns boosted by energy credit investments Jul 26 2016
Jerome Dodson Comments on Allergan Jul 26 2016
Jerome Dodson's Parnassus Fund 2nd Quarter Commentary Jul 26 2016
Street Talk: Mondelez & more Jul 25 2016
Allergan Gets Positive Opinion For Its Truberzi For Irritable Bowel Syndrome With Diarrhoea... Jul 25 2016
Credit Suisse says Allergan's drug pipeline is 'underappreciated' Jul 25 2016
Allergan Receives Positive Opinion For Truberzi® (Eluxadoline) For Treatment Of Irritable Bowel... Jul 25 2016
Allergan Receives Positive Opinion For Truberzi® (Eluxadoline) For Treatment Of Irritable Bowel... Jul 25 2016
11:30 am Allergan announces the CHMP has adopted a Positive Opinion for TRUBERZI in the EU Jul 25 2016
Jim Cramer -- I Agree With the Analysts on Gap, Allergan Jul 25 2016
Why Traders Are Watching Tesla, SolarCity, Allergan & Other Stocks Today Jul 25 2016
Specialty Pharma: Earnings Better Be Good…or Else Jul 25 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK